TRAC is sharing 19 exceptional female investors who its model has shown have a keen eye for identifying future unicorns.
The board of directors for 23andMe quit following disagreements over the CEO's plans to privatize the DNA testing company.
On Sept. 23, the board of directors at 23andMe, a prominent DNA testing company, announced their resignation following a series of disagreements with CEO Ann ...